Center for Infectious Disease Research and Policy
| Abbreviation | CIDRAP |
|---|---|
| Formation | 2001 |
| Purpose | "to prevent illness and death from infectious diseases through epidemiologic research and the rapid translation of scientific information into real-world practical applications and solutions" |
|
Director
|
Michael T. Osterholm |
|
Parent organization
|
Academic Health Center |
| Affiliations | University of Minnesota |
| Website | cidrap.umn.edu |
The Center for Infectious Disease Research and Policy (CIDRAP) is a center within the University of Minnesota that focuses on addressing public health preparedness and emerging infectious disease response. It was founded in 2001 by Michael Osterholm, PhD, MPH, in order to "prevent illness and death from infectious diseases through epidemiological research and rapid translation of scientific information into real-world practical applications and solutions".
CIDRAP’s news publishing division writes news stories and maintains information on influenza, bioterrorism, and new hot topics.
The CIDRAP News team, through the CIDRAP Web site, provides daily news updates on emerging infectious diseases, such as pandemic influenza, bioterrorism, food safety, avian influenza, and emerging topics. Along with news articles, the site provides overviews on various infectious disease topics, as well as lists of recent selected literature for each topic. CIDRAP's daily news service has 8,000 current newsletter subscribers and 7,000 Twitter followers.
Antimicrobial resistance is a critical global public health issue, and antimicrobial stewardship strategies are key to curtailing the problem. CIDRAP's Antimicrobial Stewardship Project provides current, accurate, and comprehensive information on the topic and works to build an online community to address leading issues.
Wellcome Trust and CIDRAP launched the Ebola Vaccine Team B initiative in November 2014 to assist international efforts to develop in record time safe and effective vaccines against Ebola virus disease. The project includes 25 distinguished leaders in public health, medicine, bioethics, pharmaceutical manufacturing, and humanitarian relief. The experts provide a fresh perspective (a Team B analysis) of issues being addressed by international collaborators in the areas of funding, research, development, vaccine efficacy and effectiveness determination, licensure, manufacturing, and vaccination strategy (distribution and administration). To date, Team B has published its findings in the following reports:
Membership in the CIDRAP Leadership Forum (CLF) connects decision-makers to intelligence they can trust when they need it most.
CLF members connect with Michael T. Osterholm, PhD, MPH, an international authority on emerging infectious diseases, and the comprehensive team of CIDRAP experts through special communications, conference calls, Webinars, and special CLF events.
CIDRAP has served as a partner in the federal BioWatch air-monitoring program. This program is responsible for the constant monitoring for potential bioterrorism-related agents in cities throughout the United States. Through its contract with the Department of Homeland Security, CIDRAP provides support for the development of national outdoor and indoor guidance documents, a national epidemiology communications network, and a suite of related program and reference documents.
...
Wikipedia